Resource Logo
AIDS Weekly Plus

New HIV/AIDS Study Findings Have Been Reported by Researchers at Elizabeth Glaser Pediatric AIDS Foundation


2012 OCT 8 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Investigators discuss new findings in Immune System Diseases and Conditions. According to news reporting out of Washington, District of Columbia, by NewsRx editors, research stated, "Prevention of Mother-to-Child Transmission of HIV programs require follow-up of HIV-exposed infants (HEI) for infant feeding support, prophylactic medicines, and HIV diagnosis for at least 18 months. Retention in care and receipt of HIV services are challenging in resource-limited settings."

Our news journalists obtained a quote from the research from Elizabeth Glaser Pediatric AIDS Foundation, "This study compared infant follow-up results when HEI services were provided within Maternal and Child Health (MCH) clinics or in specialized HIV Comprehensive Care Clinics (CCCs) in Kenya. This observational prospective cohort study enrolled HEI at 6-8 weeks of age in 2 purposively selected hospitals with similar characteristics but different models of service delivery. In the CCC model, HEI received immunization and growth monitoring in MCH but cotrimoxazole prophylaxis and infant HIV testing in the CCC. In the MCH model, all services were provided in the MCH. Data were collected at enrollment, 14 weeks, and 6, 9, and 12 months. From April 2008 to April 2009, 184 HEI were enrolled in the CCC cohort and 179 in the MCH cohort. Infants in MCH were 1.14, 1.42, 1.95, and 1.29 times more likely to attend 14-week, 6-, 9-, and 12-month postnatal visits, respectively, and 2.24 times (95% confidence interval: 1.57 to 3.18) more likely to attend all 4 visits. Although infants in MCH were 1.33 times (95% confidence interval: 1.10 to 1.62) more likely to have HIV antibody testing at 1 year than CCC, there were no differences for polymerase chain reaction test or cotrimoxazole initiation at 6-8 weeks."

According to the news editors, the researchers concluded: "HIV services integrated in MCH yield better follow-up of HEI than CCC."

For more information on this research see: Provision of Services and Care for HIV-Exposed Infants: A Comparison of Maternal and Child Health Clinic and HIV Comprehensive Care Clinic Models. Jaids-Journal of Acquired Immune Deficiency Syndromes, 2012;61(1):83-89. Jaids-Journal of Acquired Immune Deficiency Syndromes can be contacted at: Lippincott Williams & Wilkins, 530 Walnut St, Philadelphia, PA 19106-3621, USA (see also Immune System Diseases and Conditions).

Our news journalists report that additional information may be obtained by contacting J.O. Ong'ech, Elizabeth Glaser Pediat AIDS Fdn, Washington, DC, United States.

Keywords for this news article include: HIV/AIDS, Virology, Washington, RNA Viruses, Retroviridae, United States, HIV Infections, Pediatric Vaccines, Vertebrate Viruses, District of Columbia, Primate Lentiviruses, North and Central America, Maternal and Child Health, Acquired Immunodeficiency Syndrome, Viral Sexually Transmitted Diseases

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2012, NewsRx LLC


Copyright © 2012 -AIDS Weekly Plus, Publisher. All rights reserved to Charles Henderson, Publisher. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633- 4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX:(205) 995-1588 Visit AIDS WEEKLY PLUS.

Information in this article was accurate in October 8, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.